| 1.5TMRI | 1.5 Tesla magnetic resonance imaging |
| 3TMRI | 3 Tesla magnetic resonance imaging |
| AD | Alzheimer’s disease |
| ADC | Apparent diffusion coefficient |
| ALS | Amyotrophic lateral sclerosis |
| BOLD | Blood oxygen level dependent |
| Cho | Choline |
| CMS | Cervical myelopathy scale |
| CR | Compression Ratio |
| Cr | Creatine |
| CSM | Cervical spondylotic myelopathy |
| CT | Computed tomography |
| DBSI | Diffusion basis spectrum imaging |
| DCM | Degenerative cervical myelopathy |
| DNA | Deoxyribonucleic acid |
| DTI | Diffusion tensor imaging |
| DTT | Diffusion tensor tractography |
| DWI | Diffusion weighted imaging |
| EMG | Electromyography |
| EMS | European myelopathy scale |
| FA | Fractional anisotropy |
| FC | Functional connectivity |
| fFOV | Full field of view |
| fMRI | Functional MRI |
| Glx | Glutamate-glutamine |
| Ins | Myo-inositols |
| MCC | Maximum canal compromise |
| MEPs | Motor evoked potentials |
| mJOA | Modified Japanese Orthopaedic Association scale |
| MRI | Magnetic resonance imaging |
| MRS | Magnetic resonance spectroscopy |
| MS | Multiple sclerosis |
| MSCC | Maximum spinal cord compression |
| MT | Magnetization transfer |
| MTR | Magnetization transfer ratio |
| MWF | Myelin water fraction |
| NAA | N-acetylaspartate |
| NCS | Nerve conduction studies |
| NDI | Neck disability index |
| NPRS | Numeric pain rating scale |
| OPLL | Ossification of the posterior longitudinal ligaments |
| PD | Parkinson’s disease |
| qMRI | Quantitative magnetic resonance imaging |
| QSM | Quantitative susceptibility mapping |
| R2*MRI | R2* magnetic resonance imaging |
| rFOV | Reduced field of view |
| ROI | Region of interest |
| SMA | Supplementary motor area |
| SSEPs | Somatosensory evoked potentials |
| SWI | Susceptibility weighted imaging |
| T1WI | T1 weighted imaging |
| T2*WI | T2*-weighted imaging |
| T2WI | T2 weighted imaging |
| VOA | Volume of activation |